Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax”

723 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 723 results

Early research (Phase 1)Ended earlyNCT04748848
What this trial is testing

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Who this might be right for
Leukemia, Myeloid
Celgene 1
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243
What this trial is testing

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 44
Early research (Phase 1)Study completedNCT03441555
What this trial is testing

Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 36
Testing effectiveness (Phase 2)Looking for participantsNCT03128879
What this trial is testing

Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 90
Early research (Phase 1)Study completedNCT03625505
What this trial is testing

Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 61
Testing effectiveness (Phase 2)Looking for participantsNCT06644183
What this trial is testing

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
LeukemiaRelapsed LeukemiaChronic Lymphocytic Leukemia+2 more
Jennifer R. Brown, MD, PhD 64
Testing effectiveness (Phase 2)Looking for participantsNCT05861050
What this trial is testing

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaMantle Cell LymphomaPleomorphic Variant Mantle Cell Lymphoma
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT04477486
What this trial is testing

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma (MCL)
AbbVie 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04450173
What this trial is testing

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage III Follicular LymphomaAnn Arbor Stage IV Follicular Lymphoma+3 more
University of California, Davis 40
Large-scale testing (Phase 3)Looking for participantsNCT03868722
What this trial is testing

Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment

Who this might be right for
CLL
Rigshospitalet, Denmark 212
Not applicableStudy completedNCT04826523
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 150
Testing effectiveness (Phase 2)Looking for participantsNCT06471946
What this trial is testing

VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

Who this might be right for
Higher-risk Myelodysplastic Syndromes
Navy General Hospital, Beijing 54
Large-scale testing (Phase 3)Active Not RecruitingNCT03701282
What this trial is testing

Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Cancer Institute (NCI) 720
Testing effectiveness (Phase 2)Study completedNCT04939363
What this trial is testing

Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;

Who this might be right for
Richter's Syndrome
Bnai Zion Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04722601
What this trial is testing

A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
University of Chicago 2
Testing effectiveness (Phase 2)UnknownNCT05918198
What this trial is testing

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT05853965
What this trial is testing

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in Relapse
Universitätsklinikum Hamburg-Eppendorf 45
Testing effectiveness (Phase 2)Looking for participantsNCT05807932
What this trial is testing

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Heinrich-Heine University, Duesseldorf 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04501939
What this trial is testing

Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia
University of California, San Diego 5
Testing effectiveness (Phase 2)Looking for participantsNCT05904106
What this trial is testing

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 146
Load More Results